King Pharms Llc Drug Patent Portfolio
King Pharms Llc owns 2 orange book drugs protected by 2 US patents Given below is the list of King Pharms Llc's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7368469 | Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events | 30 Aug, 2020 | Expired |
| US6066339 | Oral morphine multiparticulate formulation | 25 Nov, 2017 | Expired |
Latest Legal Activities on King Pharms Llc's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of King Pharms Llc.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 24 Oct, 2019 | US7368469 |
| Post Issue Communication - Certificate of Correction | 25 Jun, 2008 | US7368469 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 06 May, 2008 | US7368469 |
|
Recordation of Patent Grant Mailed
Critical
| 06 May, 2008 | US7368469 |
|
Issue Notification Mailed
Critical
| 16 Apr, 2008 | US7368469 |
| Dispatch to FDC | 31 Mar, 2008 | US7368469 |
| Mail Miscellaneous Communication to Applicant | 26 Mar, 2008 | US7368469 |
|
Application Is Considered Ready for Issue
Critical
| 26 Mar, 2008 | US7368469 |
| Miscellaneous Communication to Applicant - No Action Count | 20 Mar, 2008 | US7368469 |
|
Issue Fee Payment Verified
Critical
| 29 Feb, 2008 | US7368469 |
|
Issue Fee Payment Received
Critical
| 29 Feb, 2008 | US7368469 |
|
Information Disclosure Statement (IDS) Filed
Critical
| 21 Feb, 2008 | US7368469 |
|
Information Disclosure Statement considered
Critical
| 21 Feb, 2008 | US7368469 |
|
Mail Notice of Allowance
Critical
| 15 Jan, 2008 | US7368469 |
| Mail Examiner's Amendment | 15 Jan, 2008 | US7368469 |
King Pharms Llc's Family Patents
King Pharms Llc Drug List
Given below is the complete list of King Pharms Llc's drugs and the patents protecting them.
1. Altace
Altace is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7368469 | Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events |
30 Aug, 2020
(4 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Altace's drug page
2. Avinza
Avinza is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6066339 | Oral morphine multiparticulate formulation |
25 Nov, 2017
(7 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Avinza's drug page